Skip to content

AMWC 2027

AMWC 2027 takes place April 1–3 at the Palais des Festivals et des Congrès in Cannes, France. Registration, abstract submission, and exhibition opportunities are open. The organizer has published submission deadlines and registration-rate periods, while a detailed 2027 timetable and an auditable toxin-specific session list are still pending.

FieldCurrent information
DatesApril 1–3, 2027
VenuePalais des Festivals et des Congrès, Cannes, France
FormatIn person; a separate package includes selected live-streamed sessions and post-congress replay
Program statusGeneral program scope announced; detailed timetable pending
Registration statusOpen; current super-early-bird period ends October 29, 2026
Main toxin contextAesthetic medicine, injectables, scientific sessions, sponsored workshops, and exhibition activity
Last checkedJuly 29, 2026

AMWC covers aesthetic medicine, surgery, longevity, regenerative medicine, wellness, and commercial exhibition. Botulinum toxin is therefore one part of a much larger program rather than the sole scientific focus.

The organizer describes the 2027 congress as a science-led program spanning dermatology, injectables, regenerative medicine, minimally invasive procedures, and practice management. Its abstract categories 🔗 explicitly include treatment with injectables, including botulinum toxin and dermal fillers. This confirms that toxin-related work is within scope, but it does not establish which submissions will be accepted or scheduled.

A session-level schedule identifying botulinum toxin presentations, times, rooms, and access requirements was not yet published in the official pages reviewed on July 29, 2026.

Once the detailed program is available, this section should separate:

  • independent scientific sessions that explicitly address botulinum toxin
  • live demonstrations or practical sessions involving toxin injection
  • company-sponsored symposia and workshops
  • sessions that discuss injectables broadly without confirming toxin content

No product, company, speaker, or clinical claim should be attributed to the 2027 program before it appears in an official schedule or abstract record.

ActionCurrent statusPlanning note
Congress registrationOpenSuper-early-bird rates run through October 29, 2026; early-bird rates run through January 14, 2027
Abstract submissionOpenOral-presentation deadline: October 31, 2026; poster deadline: December 31, 2026
Hotel booking platformOpening soonThe organizer states that its official accommodation platform is not yet open
Sponsorship and exhibitionOpenThe 2027 congress is accepting exhibitor and sponsor participation
Detailed session planningPendingWait for the dated program before building a toxin-specific itinerary

The registration page 🔗 separates scientific-program passes from sponsored-workshop and exhibition passes. It also lists a live-stream package with access to selected sessions and post-congress replays through an AMS Premium membership; this does not imply that every room or session will be streamed.

The organizer now maintains an official 2027 exhibitors and sponsors directory 🔗 and promotes the Cannes edition as the largest exhibition floor in the event’s history. The directory is embedded through an external portal and did not expose a complete, auditable company list in the official text source reviewed, so no toxin-company participation is recorded here yet.

Future updates should distinguish exhibitors, congress sponsors, sponsored-workshop hosts, Catalyst Stage participants, speakers’ company affiliations, and brands named in the scientific program. Exhibition or sponsorship alone does not establish product approval, availability, or clinical evidence.

Scientific sessions, sponsored workshops, exhibit-floor activity, and marketing claims represent different forms of evidence. None should be used on its own to infer that toxin products are interchangeable, unit-equivalent, equally approved, safer, stronger, longer-lasting, or clinically superior.